Loading…

Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells

The effects of wortmannin and LY294002, inhibitors of PI3-kinase, in secretagogue-stimulated rat adrenal chromaffin cells loaded with Calcium Green-1 were studied by simultaneously measuring changes in the fluorescence intensity of the indicator (Ca-response) and in the release of catecholamine (sec...

Full description

Saved in:
Bibliographic Details
Published in:Cell calcium (Edinburgh) 2001-04, Vol.29 (4), p.239-247
Main Author: Warashina, A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843
cites cdi_FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843
container_end_page 247
container_issue 4
container_start_page 239
container_title Cell calcium (Edinburgh)
container_volume 29
creator Warashina, A.
description The effects of wortmannin and LY294002, inhibitors of PI3-kinase, in secretagogue-stimulated rat adrenal chromaffin cells loaded with Calcium Green-1 were studied by simultaneously measuring changes in the fluorescence intensity of the indicator (Ca-response) and in the release of catecholamine (secretory resp onse). Before application of these agents, the profile of the secretory response evoked by a 10-min stimulation with 30mM K+] was approximated by thek th (2.6 on average) power of that of the Ca-response. Both agents dose-dependently inhibited the high-K+-elicited Ca-response and secretory response in a similar mode to which the k th power relation was preserved despite the occurrence of profound changes in the shapes and sizes of these two responses. The L-type Ca2+-channel blocker PN200-110 inhibited the high-K+-evoked responses in a similar fashion. Thus, it is likely that wortmannin and LY294002 inhibit high-K+-evoked CA secretion by inhibiting a Ca2+-influx through voltage-dependent Ca2+channels. Although regulation of L-type Ca2+channel activity via PI3-kinase has been reported in vascular myocytes, this possibility may be limited in the present case since the doses of LY294002 and wortmannin used to inhibit the secretory response are much higher than IC50's for inhibition of PI3-kinase with these agents. Compared with the high-K+-elicited responses, muscarine-evoked Ca-responses and secretory responses were more strongly inhibited by wortmannin, but less affected by LY294002. The differential effects suggest that the inhibition of the muscarine-evoked secretion by these agents i s not associated with the inhibition of PI3-kinase.
doi_str_mv 10.1054/ceca.2000.0187
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76960564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0143416000901878</els_id><sourcerecordid>76960564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843</originalsourceid><addsrcrecordid>eNqFkb1rHDEQxUVIiM8fbcqgKt1eRh-3WpXG2EngQpqkSCW00iyrsKt1JJ3N_ffRcgeugqsZmN88Zt4j5AODLYOd_OzQ2S0HgC2wTr0hG7YTvGFas7dkA0yKRrIWLshlzn8qpYVi78kFY1wKLfiGzN_RjTaGPNP-SJ_H4Eb6vKQy2xhDpDZ6uv_NtQTgNMQx9KFQZ0tdWiY7h4g0o0tYwhLrnJYRabKFWp8w2onO6A_TZNOROpymfE3eDXbKeHOuV-TXw_3Pu6_N_seXb3e3-8ZJoUozgIa-0623gnOUHqUGXi_umbA9qnantfIeWu290Fa3nINnQ6-G2jrVSXFFPp10H9Py94C5mDnk9QIbcTlko1rdwq59HWSqE5opVcHtCXRpyTnhYB5TmOtjhoFZkzBrEmZNwqxJ1IWPZ-VDX114wc_WV6A7AViNeAqYTHYBo0MfErpi_BL-p_0PuCWW1w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17839177</pqid></control><display><type>article</type><title>Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Warashina, A.</creator><creatorcontrib>Warashina, A.</creatorcontrib><description>The effects of wortmannin and LY294002, inhibitors of PI3-kinase, in secretagogue-stimulated rat adrenal chromaffin cells loaded with Calcium Green-1 were studied by simultaneously measuring changes in the fluorescence intensity of the indicator (Ca-response) and in the release of catecholamine (secretory resp onse). Before application of these agents, the profile of the secretory response evoked by a 10-min stimulation with 30mM K+] was approximated by thek th (2.6 on average) power of that of the Ca-response. Both agents dose-dependently inhibited the high-K+-elicited Ca-response and secretory response in a similar mode to which the k th power relation was preserved despite the occurrence of profound changes in the shapes and sizes of these two responses. The L-type Ca2+-channel blocker PN200-110 inhibited the high-K+-evoked responses in a similar fashion. Thus, it is likely that wortmannin and LY294002 inhibit high-K+-evoked CA secretion by inhibiting a Ca2+-influx through voltage-dependent Ca2+channels. Although regulation of L-type Ca2+channel activity via PI3-kinase has been reported in vascular myocytes, this possibility may be limited in the present case since the doses of LY294002 and wortmannin used to inhibit the secretory response are much higher than IC50's for inhibition of PI3-kinase with these agents. Compared with the high-K+-elicited responses, muscarine-evoked Ca-responses and secretory responses were more strongly inhibited by wortmannin, but less affected by LY294002. The differential effects suggest that the inhibition of the muscarine-evoked secretion by these agents i s not associated with the inhibition of PI3-kinase.</description><identifier>ISSN: 0143-4160</identifier><identifier>EISSN: 1532-1991</identifier><identifier>DOI: 10.1054/ceca.2000.0187</identifier><identifier>PMID: 11243932</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adrenal Medulla - cytology ; Adrenal Medulla - secretion ; Androstadienes - pharmacology ; Animals ; Calcium - metabolism ; Catecholamines - antagonists &amp; inhibitors ; Catecholamines - secretion ; Chromaffin Cells - drug effects ; Chromaffin Cells - metabolism ; Chromaffin Cells - secretion ; Chromones - pharmacology ; Male ; Morpholines - pharmacology ; Muscarine - pharmacology ; Potassium - pharmacology ; Rats ; Rats, Wistar</subject><ispartof>Cell calcium (Edinburgh), 2001-04, Vol.29 (4), p.239-247</ispartof><rights>2001 Harcourt Publishers Ltd</rights><rights>Copyright 2001 Harcourt Publishers Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843</citedby><cites>FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11243932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Warashina, A.</creatorcontrib><title>Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells</title><title>Cell calcium (Edinburgh)</title><addtitle>Cell Calcium</addtitle><description>The effects of wortmannin and LY294002, inhibitors of PI3-kinase, in secretagogue-stimulated rat adrenal chromaffin cells loaded with Calcium Green-1 were studied by simultaneously measuring changes in the fluorescence intensity of the indicator (Ca-response) and in the release of catecholamine (secretory resp onse). Before application of these agents, the profile of the secretory response evoked by a 10-min stimulation with 30mM K+] was approximated by thek th (2.6 on average) power of that of the Ca-response. Both agents dose-dependently inhibited the high-K+-elicited Ca-response and secretory response in a similar mode to which the k th power relation was preserved despite the occurrence of profound changes in the shapes and sizes of these two responses. The L-type Ca2+-channel blocker PN200-110 inhibited the high-K+-evoked responses in a similar fashion. Thus, it is likely that wortmannin and LY294002 inhibit high-K+-evoked CA secretion by inhibiting a Ca2+-influx through voltage-dependent Ca2+channels. Although regulation of L-type Ca2+channel activity via PI3-kinase has been reported in vascular myocytes, this possibility may be limited in the present case since the doses of LY294002 and wortmannin used to inhibit the secretory response are much higher than IC50's for inhibition of PI3-kinase with these agents. Compared with the high-K+-elicited responses, muscarine-evoked Ca-responses and secretory responses were more strongly inhibited by wortmannin, but less affected by LY294002. The differential effects suggest that the inhibition of the muscarine-evoked secretion by these agents i s not associated with the inhibition of PI3-kinase.</description><subject>Adrenal Medulla - cytology</subject><subject>Adrenal Medulla - secretion</subject><subject>Androstadienes - pharmacology</subject><subject>Animals</subject><subject>Calcium - metabolism</subject><subject>Catecholamines - antagonists &amp; inhibitors</subject><subject>Catecholamines - secretion</subject><subject>Chromaffin Cells - drug effects</subject><subject>Chromaffin Cells - metabolism</subject><subject>Chromaffin Cells - secretion</subject><subject>Chromones - pharmacology</subject><subject>Male</subject><subject>Morpholines - pharmacology</subject><subject>Muscarine - pharmacology</subject><subject>Potassium - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0143-4160</issn><issn>1532-1991</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkb1rHDEQxUVIiM8fbcqgKt1eRh-3WpXG2EngQpqkSCW00iyrsKt1JJ3N_ffRcgeugqsZmN88Zt4j5AODLYOd_OzQ2S0HgC2wTr0hG7YTvGFas7dkA0yKRrIWLshlzn8qpYVi78kFY1wKLfiGzN_RjTaGPNP-SJ_H4Eb6vKQy2xhDpDZ6uv_NtQTgNMQx9KFQZ0tdWiY7h4g0o0tYwhLrnJYRabKFWp8w2onO6A_TZNOROpymfE3eDXbKeHOuV-TXw_3Pu6_N_seXb3e3-8ZJoUozgIa-0623gnOUHqUGXi_umbA9qnantfIeWu290Fa3nINnQ6-G2jrVSXFFPp10H9Py94C5mDnk9QIbcTlko1rdwq59HWSqE5opVcHtCXRpyTnhYB5TmOtjhoFZkzBrEmZNwqxJ1IWPZ-VDX114wc_WV6A7AViNeAqYTHYBo0MfErpi_BL-p_0PuCWW1w</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Warashina, A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells</title><author>Warashina, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adrenal Medulla - cytology</topic><topic>Adrenal Medulla - secretion</topic><topic>Androstadienes - pharmacology</topic><topic>Animals</topic><topic>Calcium - metabolism</topic><topic>Catecholamines - antagonists &amp; inhibitors</topic><topic>Catecholamines - secretion</topic><topic>Chromaffin Cells - drug effects</topic><topic>Chromaffin Cells - metabolism</topic><topic>Chromaffin Cells - secretion</topic><topic>Chromones - pharmacology</topic><topic>Male</topic><topic>Morpholines - pharmacology</topic><topic>Muscarine - pharmacology</topic><topic>Potassium - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Warashina, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell calcium (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Warashina, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells</atitle><jtitle>Cell calcium (Edinburgh)</jtitle><addtitle>Cell Calcium</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>29</volume><issue>4</issue><spage>239</spage><epage>247</epage><pages>239-247</pages><issn>0143-4160</issn><eissn>1532-1991</eissn><abstract>The effects of wortmannin and LY294002, inhibitors of PI3-kinase, in secretagogue-stimulated rat adrenal chromaffin cells loaded with Calcium Green-1 were studied by simultaneously measuring changes in the fluorescence intensity of the indicator (Ca-response) and in the release of catecholamine (secretory resp onse). Before application of these agents, the profile of the secretory response evoked by a 10-min stimulation with 30mM K+] was approximated by thek th (2.6 on average) power of that of the Ca-response. Both agents dose-dependently inhibited the high-K+-elicited Ca-response and secretory response in a similar mode to which the k th power relation was preserved despite the occurrence of profound changes in the shapes and sizes of these two responses. The L-type Ca2+-channel blocker PN200-110 inhibited the high-K+-evoked responses in a similar fashion. Thus, it is likely that wortmannin and LY294002 inhibit high-K+-evoked CA secretion by inhibiting a Ca2+-influx through voltage-dependent Ca2+channels. Although regulation of L-type Ca2+channel activity via PI3-kinase has been reported in vascular myocytes, this possibility may be limited in the present case since the doses of LY294002 and wortmannin used to inhibit the secretory response are much higher than IC50's for inhibition of PI3-kinase with these agents. Compared with the high-K+-elicited responses, muscarine-evoked Ca-responses and secretory responses were more strongly inhibited by wortmannin, but less affected by LY294002. The differential effects suggest that the inhibition of the muscarine-evoked secretion by these agents i s not associated with the inhibition of PI3-kinase.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>11243932</pmid><doi>10.1054/ceca.2000.0187</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-4160
ispartof Cell calcium (Edinburgh), 2001-04, Vol.29 (4), p.239-247
issn 0143-4160
1532-1991
language eng
recordid cdi_proquest_miscellaneous_76960564
source ScienceDirect Freedom Collection 2022-2024
subjects Adrenal Medulla - cytology
Adrenal Medulla - secretion
Androstadienes - pharmacology
Animals
Calcium - metabolism
Catecholamines - antagonists & inhibitors
Catecholamines - secretion
Chromaffin Cells - drug effects
Chromaffin Cells - metabolism
Chromaffin Cells - secretion
Chromones - pharmacology
Male
Morpholines - pharmacology
Muscarine - pharmacology
Potassium - pharmacology
Rats
Rats, Wistar
title Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A27%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20by%20which%20wortmannin%20and%20LY294002%20inhibit%20catecholamine%20secretion%20in%20the%20rat%20adrenal%20medullary%20cells&rft.jtitle=Cell%20calcium%20(Edinburgh)&rft.au=Warashina,%20A.&rft.date=2001-04-01&rft.volume=29&rft.issue=4&rft.spage=239&rft.epage=247&rft.pages=239-247&rft.issn=0143-4160&rft.eissn=1532-1991&rft_id=info:doi/10.1054/ceca.2000.0187&rft_dat=%3Cproquest_cross%3E76960564%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c437t-f090b896da322e4de4902243b13abe765997dd069dd39a96220d1fb7f962c7843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17839177&rft_id=info:pmid/11243932&rfr_iscdi=true